Introduction

As the global pharmaceutical industry accelerates the development of innovative small-molecule therapeutics, demand for high-purity aromatic intermediates continues to grow. Among these compounds, 4-Bromo-3-fluoro-2-methylaniline (CAS No. 127408-03-1) has become an increasingly important fluorinated building block used in advanced medicinal chemistry.

This compound serves as a valuable synthetic intermediate in the preparation of several heterocyclic molecules, particularly 5-Bromo-4-fluoro-1H-indazole and 5-bromo-1-cyclopropyl-4-fluoro-1H-indazole, which are recognized intermediates in the synthetic route toward Orforglipron, one of the most promising oral GLP-1 receptor agonists currently under development.

As pharmaceutical manufacturers seek reliable supply chains for complex intermediates, selecting an experienced production partner capable of delivering consistent quality, scalable capacity, and regulatory-compliant manufacturing has become increasingly important.

What is 4-Bromo-3-fluoro-2-methylaniline?

4-Bromo-3-fluoro-2-methylaniline

CAS No.: 127408-03-1

Molecular Formula: C₇H₇BrFN

Molecular Weight: 204.04 g/mol

4-Bromo-3-fluoro-2-methylaniline is a brominated and fluorinated aromatic amine widely used as an advanced pharmaceutical intermediate. The combination of bromine and fluorine substituents provides excellent synthetic flexibility, allowing chemists to construct highly functionalized heterocyclic compounds through various coupling, cyclization, and substitution reactions.

The product is typically supplied as a solid with high chemical purity suitable for pharmaceutical research, process development, and commercial manufacturing. Proper storage under dry, sealed conditions is recommended to maintain product stability.

Physical and Chemical Properties

Some typical characteristics of 4-Bromo-3-fluoro-2-methylaniline include:

The bromine atom serves as an excellent leaving group for palladium-catalyzed cross-coupling reactions, while the fluorine substituent contributes to improved metabolic stability in downstream pharmaceutical molecules. These characteristics make this intermediate particularly attractive for medicinal chemistry programs.

Why is 4-Bromo-3-fluoro-2-methylaniline Important?

Fluorinated aromatic amines have become indispensable building blocks in modern drug discovery.

Compared with conventional aromatic intermediates, fluorinated compounds often provide:

• · Enhanced biological activity
• · Improved metabolic stability
• · Better receptor selectivity
• · Optimized pharmacokinetic properties
• · Increased chemical diversity for lead optimization

Consequently, pharmaceutical companies increasingly incorporate fluorinated intermediates into the synthesis of oncology, metabolic disease, antiviral, and central nervous system drug candidates.

4-Bromo-3-fluoro-2-methylaniline represents one of these highly versatile intermediates that supports multiple synthetic pathways.

Role in Orforglipron Intermediate Synthesis

One of the fastest-growing applications of 4-Bromo-3-fluoro-2-methylaniline is its use as a key precursor in the preparation of Orforglipron synthetic intermediates.

During multi-step synthesis, this compound can be transformed into important indazole derivatives including:

• · 5-Bromo-4-fluoro-1H-indazole 
• · 5-bromo-1-cyclopropyl-4-fluoro-1H-indazole 

These intermediates are widely recognized as important building blocks within reported synthetic routes toward Orforglipron, an investigational oral, non-peptide GLP-1 receptor agonist being developed for obesity and type 2 diabetes treatment.

As global interest in GLP-1 therapies continues to expand, demand for reliable upstream intermediates is expected to increase significantly.

Growing Market Demand

The pharmaceutical intermediate market has experienced rapid expansion over the past decade.

Several factors are driving increased demand for compounds such as 4-Bromo-3-fluoro-2-methylaniline:

Expansion of GLP-1 Drug Development

GLP-1 receptor agonists have become one of the fastest-growing therapeutic categories worldwide. Oral small-molecule candidates such as Orforglipron are attracting significant investment because they may provide easier administration compared with injectable therapies.

Increasing Fluorinated Drug Development

Nearly one-third of newly approved small-molecule drugs contain fluorine atoms, reflecting the pharmaceutical industry’s growing reliance on fluorinated chemistry.

Outsourcing of Pharmaceutical Manufacturing

Many global pharmaceutical companies now outsource intermediate manufacturing to specialized suppliers with expertise in fluorination, bromination, and custom synthesis.

This trend creates strong opportunities for qualified manufacturers capable of delivering consistent quality and scalable production.

Applications Beyond Orforglipron

Although Orforglipron has attracted considerable attention, this intermediate also finds application in other research areas.

Typical applications include:

• · Pharmaceutical intermediate synthesis
• · Fluorinated heterocycle preparation
• · Indazole derivative development
• · Medicinal chemistry research
• · Process development
• · Custom synthesis projects
• · CRO and CDMO manufacturing

Its versatility makes it valuable for both early-stage drug discovery and commercial-scale production.

Why Choose SHLZ Pharma?

At SHLZ Pharma, we specialize in the development and manufacturing of high-quality pharmaceutical intermediates, fine chemicals, and custom synthesis products.

Our technical team has accumulated extensive experience in halogenated aromatic compounds, enabling us to provide customers with reliable products that meet demanding pharmaceutical standards.

Our advantages include:

Stable Manufacturing Process

Optimized synthetic routes ensure excellent batch-to-batch consistency while maintaining high purity and production efficiency.

High Product Purity

We implement rigorous quality control procedures using advanced analytical instruments to ensure every batch meets customer specifications.

Flexible Production Capacity

From laboratory quantities to commercial-scale production, SHLZ Pharma offers flexible manufacturing solutions that support customers throughout every development stage.

Professional Custom Synthesis

In addition to catalog products, we provide customized synthesis services for pharmaceutical intermediates, helping accelerate drug development projects.

Global Supply Capability

With extensive export experience, SHLZ Pharma supplies pharmaceutical intermediates to customers across Asia, Europe, North America, and other international markets, supported by professional logistics and responsive technical service.

Conclusion

As innovative oral GLP-1 therapies continue to reshape the pharmaceutical landscape, reliable upstream intermediates have become increasingly valuable.

4-Bromo-3-fluoro-2-methylaniline (CAS 127408-03-1) plays an important role as a versatile fluorinated aromatic intermediate, particularly in the synthesis of 5-Bromo-4-fluoro-1H-indazole, 5-bromo-1-cyclopropyl-4-fluoro-1H-indazole, and related intermediates used in reported Orforglipron synthetic routes. Its excellent reactivity, broad applicability, and growing market demand make it an essential building block for modern pharmaceutical manufacturing.

Whether you require research quantities, pilot-scale production, or long-term commercial supply, SHLZ Pharma is committed to providing high-quality pharmaceutical intermediates backed by reliable manufacturing, strict quality control, and professional technical support.